Legal & General Group Plc - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 52 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 2.3%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,241
-95.5%
3,029
-89.1%
0.00%
Q2 2023$72,151
+42.6%
27,911
+125.1%
0.00%
Q1 2023$50,600
-13.2%
12,402
+6.9%
0.00%
Q4 2022$58,262
-61.4%
11,6060.0%0.00%
Q3 2022$151,000
+10.2%
11,606
+8.8%
0.00%
Q2 2022$137,000
-14.4%
10,666
+1.4%
0.00%
Q1 2022$160,000
-14.0%
10,5180.0%0.00%
Q4 2021$186,000
-15.8%
10,5180.0%0.00%
Q3 2021$221,000
+154.0%
10,518
+136.1%
0.00%
Q2 2021$87,000
+8.8%
4,455
+62.5%
0.00%
Q1 2021$80,000
-7.0%
2,742
-3.8%
0.00%
Q4 2020$86,000
+91.1%
2,8500.0%0.00%
Q3 2020$45,000
-40.0%
2,850
-24.9%
0.00%
Q2 2020$75,000
+53.1%
3,794
+1.2%
0.00%
Q1 2020$49,000
-46.7%
3,749
-25.1%
0.00%
Q4 2019$92,000
+557.1%
5,006
+400.6%
0.00%
Q3 2019$14,000
-6.7%
1,0000.0%0.00%
Q2 2019$15,0001,0000.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Column Group LLC 18,136,735$232,513,00049.48%
Ponoi II Management, LLC 1,298,908$16,652,00045.25%
Ponoi Management, LLC 1,298,908$16,652,00026.29%
Euclidean Capital LLC 746,674$9,572,0008.14%
StepStone Group LP 1,573,357$20,170,0002.16%
First Light Asset Management, LLC 1,135,884$14,562,0001.69%
Lexington Partners L.P. 110,428$1,416,0000.73%
Rubric Capital Management LP 797,588$10,225,0000.54%
Boxer Capital, LLC 500,000$6,410,0000.41%
DAFNA Capital Management LLC 107,653$1,380,0000.38%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders